Dr Reddys Lab gains on reporting 67% jump in Q4FY13 consolidated net

15 May 2013 Evaluate

Dr Reddys Lab is currently trading at Rs. 2069.10, up by 43.45 points or 2.14% from its previous closing of Rs. 2025.65 on the BSE.

The scrip opened at Rs. 2040.00 and has touched a high and low of Rs. 2072.40 and Rs. 2040.00 respectively. So far 21,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2150.90 on 13-May-2013 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 2150.90 and Rs. 1970.25 respectively. The current market cap of the company is Rs. 32,125 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 40.69% and 16.90% respectively.

Dr Reddys Laboratories has reported results for quarter and year ended March 31, 2013.

The company’s net profit surged by 78.55% at Rs 378.15 crore for Q4FY13 as compared to Rs 211.79 crore in Q4FY12. Its total income increased by 19.51% to Rs 2451.27 crore in the quarter under review from Rs 2051.18 crore  in the corresponding quarter of the previous year.

On consolidated basis, company’s net profit surged by 66.59% at Rs 570.89 crore for Q4FY13 as compared to Rs 342.70 crore in Q4FY12. Its total income increased by 30.80% at Rs 3503.04 crore  in the quarter under review from Rs 2678.25 crore in the corresponding quarter of the previous year.

For the full year ended March 31, 2013, the company’s net profit jumped higher by 38.70% at Rs 1265.47 crore as against Rs 912.36 crore in the FY 12. Its total income 25.72% at Rs 8575.72 crore from the quarter under review as compared to Rs 6821.48 crore in corresponding quarter of the previous year.

On consolidated basis, the full year ended March 31, 2013, the group’s net profit grew by 17.63% at Rs 1677.62 crore as against Rs 1426.21 crore in the FY12. Its total income rose by 21.79% at Rs 11874.46 crore from the year as compared to Rs 9750.24 crore in previous fiscal.

The company’ board of directors of the company at its meeting held on May 14, 2013, has recommended a final dividend of Rs 15 (300%) per equity share of Rs 5 face value, for the financial year 2012-13.

Dr. Reddys Lab Share Price

1279.65 6.70 (0.53%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×